Join the club for FREE to access the whole archive and other member benefits.

Underdog Pharmaceuticals

Company developing simple and direct interventions targeting toxic forms of cholesterol for age-related diseases.

Underdog Pharmaceuticals, Inc., is pursuing a mission to treat the underlying causes of age-related disease. The company develops simple and direct interventions targeting toxic forms of cholesterol, using rationally designed molecules, to provide the first true disease-modifying treatments for age-related diseases such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration.

Underdog was built from an SRF flagship program that has driven two years of applied development designed to explore and repair the underlying causes of cardiovascular disease. Its co-founders are Matthew O’Connor, Ph.D., and Michael Kope, formerly the Vice President of Research and the founding Chief Executive Officer, respectively, of SRF. 

Visit website: https://underdogpharma.com/

See also: Institute SENS Research Foundation

People at Underdog Pharmaceuticals

Company Representative

Co-Chief Executive Officer and Co-founder of Underdog Pharmaceuticals.

Company Representative

Co-Chief Executive Officer and Co-founder Underdog Pharmaceuticals

Underdog Pharmaceuticals News

Two drug molecules delivered via nanoparticles to combat atherosclerosis

Life Extension Advocacy Foundation (LEAF) - 26-Jun-2020

Success in mice model gives hope for fighting cholesterol-associated inflammatory diseases

Read more...

Fight Aging! reports back from SENS Research Foundation Pitch Day - Part 1

Fight Aging! - 20-Jan-2020

A stunning array of ideas - any of which on their own would be truly revolutionary

Read more...